In situ Perturb-seq applied to A375 melanoma tumors
Abstract
In situ Perturb-seq is a method for pooled optical genetic screens with spatial transcriptomics readouts in the intact tissue. Here in situ Perturb-seq was applied to A375 melanoma tumors in NSG mice to investigate top T cell receptor (TCR)-specific immunomodulating hits identified in the melanoma CRISPR activation screens.
Publication details
- Journal / source
- Figshare
- Publication date
- 1 January 2026
- Document type
- Dataset